Oncolytics Biotech Inc Capital Reinvestment Ratio

Latest as of June 2018: 0.06x

Oncolytics Biotech Inc capital reinvestment ratio. Oncolytics Biotech Inc (ONC) has a Capital Reinvestment Ratio of 0.06x as of June 2018, meaning it reinvests 0% of its operating cash flow (CA$589.26K) in capital expenditures (CA$37.44K). Check Oncolytics Biotech Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.06x

Capex / Operating Cash Flow

Operating Cash Flow

CA$589.26K

CAD

Capital Expenditures

CA$37.44K

CAD

Data as of

Jun 2018

Most recent filing

Oncolytics Biotech Inc Capital Reinvestment Ratio by Year (None–None)

Oncolytics Biotech Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Oncolytics Biotech Inc cash flow conversion.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow